The Philippine General Hospital, simply referred to as UP–PGH or PGH, is a tertiary state-owned hospital administered and operated by the University of the Philippines Manila. It is designated as the National University Hospital, and the national government referral center.

During the past decade, Philippine General Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 18 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 10 clinical trials were completed. i.e. 58.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Philippine General Hospital" #1 sponsor was "University of the Philippines" with 7 trials, followed by "Pfizer" with 5 trials sponsored, "Population Health Research Institute" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Philippine General Hospital" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "B.Braun Surgical SA" with 1 trials as a collaborator and "Basilea Pharmaceutica" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Philippine General Hospital" are "Asthma" (2 trials), "Breast Cancer" (2 trials), "Cerebral Infarction" (2 trials), "Covid19" (2 trials) and "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Philippine General Hospital" in a lesser frequency.

Most popular intervention types in "Philippine General Hospital" are "Drug" (38 trials), "Biological" (10 trials), "Other" (4 trials), "Dietary Supplement" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Bismuth-Containing Quadruple Therapy" (2 trials), "Carboplatin" (2 trials), "Lansoprazole" (2 trials) and "Lansoprazole Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Philippine General Hospital" are 51 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Philippine General Hospital". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Philippine General Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Philippine General Hospital, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 2 trials that are defined as “Not Applicable".